{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T08:06:46Z","timestamp":1766390806871},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,4,1]],"date-time":"2011-04-01T00:00:00Z","timestamp":1301616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2011,4]]},"DOI":"10.1016\/j.amjopharm.2011.03.002","type":"journal-article","created":{"date-parts":[[2011,4,21]],"date-time":"2011-04-21T21:14:56Z","timestamp":1303420496000},"page":"133-137","source":"Crossref","is-referenced-by-count":4,"title":["Balance Control Improves Following Replacement of Paroxetine with Venlafaxine and Levodopa in a Case of Microvascular Dementia"],"prefix":"10.1016","volume":"9","author":[{"given":"Jaime","family":"McDonald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Corbeil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuelle","family":"Pourcher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2011.03.002_bib1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.neucli.2008.07.006","article-title":"Postural disorders in Parkinson's disease","volume":"38","author":"Benatru","year":"2008","journal-title":"Neurophysiol Clin"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib2","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0031-9384(02)00935-6","article-title":"Neural substrates linking balance control and anxiety","volume":"77","author":"Balaban","year":"2002","journal-title":"Physiol Behav"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib3","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1586\/14737175.9.2.279","article-title":"Postural instability in Parkinson's disease: the adrenergic hypothesis and the locus coeruleus","volume":"9","author":"Grimbergen","year":"2009","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0966-6362(01)00156-4","article-title":"Attention and the control of posture and gait: a review of an emerging area of research","volume":"16","author":"Woollacott","year":"2002","journal-title":"Gait Posture"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib5","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.gaitpost.2006.11.204","article-title":"Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults","volume":"26","author":"Cham","year":"2007","journal-title":"Gait Posture"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.4088\/JCP.v63n1012","article-title":"Risk factors for falls during treatment of late-life depression","volume":"63","author":"Joo","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib7","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1016\/j.clinph.2008.07.220","article-title":"The clinical utility of posturography","volume":"119","author":"Visser","year":"2008","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1532-5415.1990.tb01588.x","article-title":"Aging and postural control","volume":"38","author":"Maki","year":"1990","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1017\/S1461145705006413","article-title":"Differential physiological effects of a low dose and high doses of venlafaxine in major depression","volume":"10","author":"Debonnel","year":"2007","journal-title":"Int J Neurosychopharmacol"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib10","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1017\/S1092852900019726","article-title":"SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants","volume":"10","author":"Stahl","year":"2005","journal-title":"CNS Spectr"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib11","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1176\/ajp.146.10.1352a","article-title":"Fluoxetine and extrapyramidal side effects","volume":"146","author":"Bouchard","year":"1989","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1177\/026988110101500303","article-title":"A randomized, double-blind controlled comparison of nefazodone and paroxetine in the treatment of depression: safety, tolerability and efficacy in continuation phase treatment","volume":"15","author":"Baldwin","year":"2001","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jns.2009.08.031","article-title":"Cardiovascular autonomic dysfunction in Parkinson's disease","volume":"289","author":"Ziemssen","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.amjopharm.2011.03.002_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1002\/mds.21428","article-title":"Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson's disease","volume":"22","author":"Schoffer","year":"2007","journal-title":"Mov Disord"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594611000468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T08:20:15Z","timestamp":1543825215000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594611000468"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,4]]}},"alternative-id":["S1543594611000468"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2011.03.002","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2011,4]]}}}